Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

3(50.0%)

Phase 2

1(16.7%)

Phase 4

1(16.7%)

N/A

1(16.7%)

6Total

Phase 3(3)

Phase 2(1)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT04053816Phase 3Completed

Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter

Role: collaborator

NCT05432739Recruiting

Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study

Role: collaborator

NCT05799300Unknown

Haemodynamic Effects of Low-dose Spinal Anaesthesia for Hip Fracture Surgery.

Role: lead

NCT04382508Unknown

Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.

Role: collaborator

NCT01431859Phase 4Unknown

Can we Help People With the Oral Allergy Syndrome Eat Fresh Fruit?

Role: lead

NCT02711540Unknown

Retrospective Analysis of Procedural Aspects of Transcatheter Aortic Valve Implantation (TAVI) on Peri-procedural Stroke

Role: lead

NCT01560455Phase 3Completed

European Bifurcation Club Trial - Two-stent Versus One-stent Technique for Large Bifurcation Lesions

Role: lead

NCT02700633Unknown

Does Permanent Pacemaker Status Confer Mortality Benefit in the Short Term Post TAVI

Role: lead

NCT02695147Unknown

Direct Aortic vs Subclavian Access for TAVI: a Review of the Outcomes in the UK

Role: lead

NCT01523158Not ApplicableTerminated

Mechanisms of Allergen Immunotherapy

Role: lead

NCT00490789Phase 2Unknown

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Role: collaborator

NCT00351260Phase 3Completed

BBC ONE - British Bifurcation Coronary Study

Role: lead

All 12 trials loaded